glp-1 lawsuit in louisiana drugs more likely to be prescribed for women than men semaglutide gastrointestinal obstruction class action

A 2022 clinical trial funded by Novo Nordisk (which makes Ozempic and Wegovy) found that a weekly dose of one GLP-1 drug reduced heavy-drinking days and total intake for people struggling with alcohol use disorder but only in a subgroup of patients with a BMI over 30

our energy currency

Optimiza la quema de grasa y mejora tu rendimiento con Mega L-Carnitine

You might be taking the right dose at the right frequency but getting subtherapeutic blood levels because half the semaglutide or tirzepatide has degraded

Breakfast can set the tone for the entire day

The risk of opioid-related overdose or overdose-related death is increased with higher opioid doses, and this risk persists over the course of therapy